Treatment of heart failure with enoximone, a new phosphodiesterase inhibitor. Düsseldorf, Federal Republic of Germany. September 25-27, 1987. Proceedings

No authors listed

No authors listed. J Cardiovasc Pharmacol. 1989.

. 1989:14 Suppl 1:S1-S83.

No abstract available

Similar articles

[Enoximone].
Ventura G. Ventura G. Medicina (Firenze). 1990 Apr-Jun;10(2):191-3. Medicina (Firenze). 1990. PMID: 2148796 Clinical Trial. Italian.
Enoximone.
[No authors listed] [No authors listed] Lancet. 1988 May 14;1(8594):1085-6. Lancet. 1988. PMID: 2896916 Review. No abstract available.
Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT, Janicki JS, Jain MC. Weber KT, et al. J Heart Transplant. 1986 Mar-Apr;5(2):105-12. J Heart Transplant. 1986. PMID: 2956397
A symposium: The use of enoximone in heart failure. September 14, 1986, Washington, D.C. Proceedings.
[No authors listed] [No authors listed] Am J Cardiol. 1987 Aug 14;60(5):1C-90C. Am J Cardiol. 1987. PMID: 2956860 No abstract available.
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
Colucci WS, Wright RF, Braunwald E. Colucci WS, et al. N Engl J Med. 1986 Feb 6;314(6):349-58. doi: 10.1056/NEJM198602063140605. N Engl J Med. 1986. PMID: 2418353 Review. No abstract available.